论文部分内容阅读
1997年12月,当同济医院普通外科研究室副主任、肝胆外科研究员蔡红娇教授研究的“体外培育牛黄”获得卫生部颁发的新药证书时,国内外医药界为之瞩目,体外培育牛黄是湖北省自解放以来诞生的第一个国家一类新药,填补国内外空白,被武汉市科技界评为98年度十大科技新闻之一。“千金易得,牛黄难求”。要实现困扰医药界百年的梦想,谈何容易,体外培育牛黄的发明者蔡红娇教授二十年的艰苦探索历程,催人泪下……
December 1997, when the Tongji Hospital, General Surgery, deputy director of the General Hospital, hepatobiliary surgery researcher Professor Cai Hongjiao research “in vitro cultivation of Bezoar ” obtained a new drug certificate issued by the Ministry of Health, the pharmaceutical industry at home and abroad for its attention, in vitro cultivation of bezoar is Hubei Province since the liberation of the birth of the first national class of new drugs to fill the gap at home and abroad, science and technology in Wuhan City was named one of the 98 top ten science and technology news. “Daughter easy to get, bezoar hard to find ”. In order to realize the dream that has bothered the pharmaceutical industry for a hundred years, how easy it is to talk about it is that Professor Cai Hongjiao, the inventor of in vitro cultivation of bezoar,